Erika Stallings is originally from North Carolina and is a graduate of the University of North Carolina-Chapel Hill and Georgetown University Law Center. She currently works as a litigation and intellectual property associate at Akerman LLP.
In the summer of 2014, Erika underwent genetic testing and learned that she was the carrier of a BRCA2 mutation, which gave her a 60-70% lifetime risk of developing breast cancer. In December 2014, she underwent a preventative double mastectomy and lowered her risk of developing breast cancer to less than 5%. Since then she uses her spare time to educate other young women about risk factors for breast cancer and ways to be proactive about their health.
Please visit this link to read her recent article outlining the importance of genetic testing for inherited cancer predisposition among Black women, in which results from our recently published study were included. Please also watch her interview here, which addresses some of the topics from the article.